These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5632452)

  • 1. [Effect of 1,2-diphenyl-3,5-diexe-4-n-butyl-pyrazolidine on the permaeability of blood-brain-barrier in animal experiments].
    Tzonos T
    Arzneimittelforschung; 1967 Apr; 17(4):509-11. PubMed ID: 5632452
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine. I. Distribution in organism after a single intravenous injection].
    HEISE ER; KIMBEL KH
    Arzneimittelforschung; 1956 Dec; 6(12):722-4. PubMed ID: 13395933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C; Schütz H
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine in rats. II. Distribution of the drug in the organism after repeated oral doses].
    HEISE ER
    Arzneimittelforschung; 1956 Dec; 6(12):724-6. PubMed ID: 13395934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3, 5-pyrazolidine-dione. 1. Theoretical basis].
    von SCHWEINITZ H; LINDNER J; ECKSTEIN M
    Arzneimittelforschung; 1960 Nov; 10():899-901. PubMed ID: 13749227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine (butazolidine) on cortisone metabolism in rat liver].
    DIRSCHERL W; KORUS W; SCHRIEFERS H
    Arzneimittelforschung; 1956 Oct; 6(10):596-8. PubMed ID: 13373678
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research on the hemato-encephalic barrier; effect of fractioned doses of pentamethylenetetrazol (cardiazol) on the blood-brain barrier and the capacity of butyl-beta-bromallylbarbituric acid sodium (pernocton) to invalidate the effect of cardiazol on the barrier].
    LEONHARDT H
    Arztl Forsch; 1957 Jul; 11(7):352-5. PubMed ID: 13457979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protein binding of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and several other drugs].
    WUNDERLY C
    Arzneimittelforschung; 1956 Dec; 6(12):731-4. PubMed ID: 13395938
    [No Abstract]   [Full Text] [Related]  

  • 12. [The mechanism of action of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine; complex forming ability of this compound and effects on diphosphopyridine nucleotide-dependent zinc enzymes].
    WALLENFELS K; SUND H
    Arzneimittelforschung; 1959 Feb; 9(2):81-9. PubMed ID: 13638188
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the blood-brain barrier to low molecular weight substances. An ultrastructural cytochemical study.
    Feria-Velasco A; Camacho-García R; Tapia-Arizmendi G
    Arch Invest Med (Mex); 1980; 11(1):95-105. PubMed ID: 7396637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexamethasone on abnormal permeability of the blood brain barrier following cerebral injury in cats.
    Rovit RL; Hagan R
    Surg Forum; 1965; 16():442-4. PubMed ID: 5835222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Penetration of human aqueous humor by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (butazolidin)].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1958; 160(2):181-5. PubMed ID: 13545132
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of 1-phenyl-3,5-dioxo-4-n-butyl-pyrazolidine on hyaluronidase spreading].
    MATHIES H; WILL E; SCHUELE V
    Med Monatsschr; 1962 Aug; 16():537-40. PubMed ID: 14471124
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Influence of free serotonin on the blood-brain barrier and the regulation of autonomic functions.
    Winkelmüller W; Markakis E; Hünefeld HW; Kersting G
    Acta Neurochir (Wien); 1975; 31(3-4):299. PubMed ID: 1181888
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbiological transformation of 1,2-diphenyl-3,5 dioxo-4-n-butyl pyrazolidine (phenylbutazone).
    Favero J; Winternitz F
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):1-7. PubMed ID: 7389746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the pharmacology of 1-phenyl-2,3-dimethyl-4-isopropylaminopyrazolone (isopyrin) and 1,2-diphenyl-4-butyl-3,5-pyradolidinedione (phenylbutazone)].
    SCHOETENSACK W; RICHARZ G; BISCHLER P
    Arzneimittelforschung; 1960 Aug; 10():665-76. PubMed ID: 13748426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Painful shoulder: treatment by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine].
    LEITAO A
    Hospital (Rio J); 1958 Sep; 54(3):335-8. PubMed ID: 13586748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.